Stock price
Market cap
At each fiscal year end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2017, ended Aug 31, 2017 | $36.9B |
| FY2018, ended Aug 30, 2018 | $59.8B |
| FY2019, ended Aug 29, 2019 | $49.5B |
| FY2020, ended Sep 3, 2020 | $51.6B |
| FY2021, ended Sep 2, 2021 | $82.8B |
| FY2022, ended Sep 1, 2022 | $62.3B |
| FY2023, ended Aug 31, 2023 | $76.8B |
| FY2024, ended Aug 29, 2024 | $106B |
| FY2025, ended Aug 28, 2025 | $137B |
| FY2026, ended Sep 3, 2026 | $1.08T |
Revenue
By fiscal year
Show tableHide table
| Period | Revenue |
|---|---|
| FY2017, ended Aug 31, 2017 | $20.3B |
| FY2018, ended Aug 30, 2018 | $30.4B |
| FY2019, ended Aug 29, 2019 | $23.4B |
| FY2020, ended Sep 3, 2020 | $21.4B |
| FY2021, ended Sep 2, 2021 | $27.7B |
| FY2022, ended Sep 1, 2022 | $30.8B |
| FY2023, ended Aug 31, 2023 | $15.5B |
| FY2024, ended Aug 29, 2024 | $25.1B |
| FY2025, ended Aug 28, 2025 | $37.4B |
| FY2026, ended Sep 3, 2026 | $133B |
Net income and free cash flow
By fiscal year. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2017, ended Aug 31, 2017 | $5.09B | $3.42B |
| FY2018, ended Aug 30, 2018 | $14.1B | $8.52B |
| FY2019, ended Aug 29, 2019 | $6.31B | $3.41B |
| FY2020, ended Sep 3, 2020 | $2.69B | $83.0M |
| FY2021, ended Sep 2, 2021 | $5.86B | $2.44B |
| FY2022, ended Sep 1, 2022 | $8.69B | $3.11B |
| FY2023, ended Aug 31, 2023 | −$5.83B | −$6.12B |
| FY2024, ended Aug 29, 2024 | $778M | $121M |
| FY2025, ended Aug 28, 2025 | $8.54B | $1.67B |
| FY2026, ended Sep 3, 2026 | $85.0B | $59.0B |
Cash and cash equivalents
At each fiscal year end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2017, ended Aug 31, 2017 | $5.11B |
| FY2018, ended Aug 30, 2018 | $6.51B |
| FY2019, ended Aug 29, 2019 | $7.15B |
| FY2020, ended Sep 3, 2020 | $7.62B |
| FY2021, ended Sep 2, 2021 | $7.76B |
| FY2022, ended Sep 1, 2022 | $8.26B |
| FY2023, ended Aug 31, 2023 | $8.58B |
| FY2024, ended Aug 29, 2024 | $7.04B |
| FY2025, ended Aug 28, 2025 | $9.64B |
| FY2026, ended Sep 3, 2026 | $38.4B |
Total debt
At each fiscal year end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2017, ended Aug 31, 2017 | $11.1B |
| FY2018, ended Aug 30, 2018 | $4.64B |
| FY2019, ended Aug 29, 2019 | $5.85B |
| FY2020, ended Sep 3, 2020 | $6.16B |
| FY2021, ended Sep 2, 2021 | $5.97B |
| FY2022, ended Sep 1, 2022 | $6.02B |
| FY2023, ended Aug 31, 2023 | $12.0B |
| FY2024, ended Aug 29, 2024 | $11.3B |
| FY2025, ended Aug 28, 2025 | $11.5B |
| FY2026, ended Sep 3, 2026 | $2.79B |
Shares outstanding
At each fiscal year end, adjusted for splits. Down 1.9% since FY17.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2017, ended Aug 31, 2017 | 1.15B |
| FY2018, ended Aug 30, 2018 | 1.13B |
| FY2019, ended Aug 29, 2019 | 1.11B |
| FY2020, ended Sep 3, 2020 | 1.11B |
| FY2021, ended Sep 2, 2021 | 1.12B |
| FY2022, ended Sep 1, 2022 | 1.09B |
| FY2023, ended Aug 31, 2023 | 1.10B |
| FY2024, ended Aug 29, 2024 | 1.11B |
| FY2025, ended Aug 28, 2025 | 1.12B |
| FY2026, ended Sep 3, 2026 | 1.13B |
Buybacks and new shares
By fiscal year, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash | Used in acquisitions |
|---|---|---|---|---|
| FY2017, ended Aug 31, 2017 | $36.0M | $215M | — | $995M |
| FY2018, ended Aug 30, 2018 | $71.0M | $198M | $1.36B | — |
| FY2019, ended Aug 29, 2019 | $2.73B | $243M | — | — |
| FY2020, ended Sep 3, 2020 | $176M | $328M | — | — |
| FY2021, ended Sep 2, 2021 | $1.20B | $378M | — | — |
| FY2022, ended Sep 1, 2022 | $2.43B | $514M | — | — |
| FY2023, ended Aug 31, 2023 | $425M | $596M | — | — |
| FY2024, ended Aug 29, 2024 | $300M | $833M | — | — |
| FY2025, ended Aug 28, 2025 | $0 | $972M | — | — |
| FY2026, ended Sep 3, 2026 | $650M | $1.33B | — | — |
Valuation
At current price- Market Cap
- $1.05T
- P/E
- 12.4×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 7.9×
- Price / Book
- 7.6×
- EV / EBITDA
- 9.3×
Growth
Trailing 12 months- Revenue (TTM)
- $133B
- Revenue Growth YoY
- 256%
- Revenue CAGR 3Y
- 105%
- Revenue CAGR 5Y
- 36.9%
- EPS Growth YoY
- 879%
- Net Income Growth YoY
- 895%
Profitability
Trailing 12 months- Gross Margin
- 80.7%
- Operating Margin
- 74.6%
- Net Margin
- 63.8%
- FCF Margin
- 44.3%
- Return on Equity
- 88.3%
Earnings
Trailing 12 months- Net Income
- $85.0B
- EPS (diluted)
- $74.33
- EBITDA
- $109B
- Operating Income
- $99.3B
Balance Sheet
As of Sep 3, 2026- Cash and cash equivalents
- $38.4B
- Total Debt
- $2.79B
- Net Cash
- $35.6B
- Total Assets
- $196B
- Total Liabilities
- $57.5B
- Shareholders' Equity
- $138B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $89.7B
- Capital Expenditure
- $30.7B
- Free Cash Flow
- $59.0B
Dividends and risk
Last 12 months- Dividend Yield
- 0.1%
- Dividend / Share
- $0.57
- Beta (5Y)
- 2.22
Every ratio is calculated from the company’s reported figures.